Samsung Biologics strike pauses; wage gap remains

Samsung Biologics workers in Incheon ended a general strike after court intervention, but the wage and personnel-system disputes remain unresolved. The May walkout cost about 150 billion won, roughly 25% of Q2 operating profit, per the union's accounting.

Share
Samsung Biologics factory in Incheon, South Korea, during the November 2026 general strike